HCV Archives – Page 20 of 30 – Treatment Action Group

1st Hepatitis C Virus World Community Advisory Board Report

July 11, 2014
Chad Cipiti

PILLS COST PENNIES, GREED COSTS LIVES July 14, 2014 By Odilon Couzin and Karyn Kaplan About the Hepatitis C Virus World Community Advisory Board Since the early years of the AIDS epidemic, people living with HIV/AIDS and their allies have…

New Hepatitis Resolution Is Passed at World Health Assembly; Challenges World Health Organization and Member States to Act

May 22, 2014
Chad Cipiti

Today, four years after introducing its first viral hepatitis resolution, the World Health Assembly (WHA)—the decision-making body of the World Health Organization (WHO)—passed the Hepatitis Resolution, which commits the WHO and United Nations (UN) member states to urgent action to address the global hepatitis pandemic, including that of hepatitis C virus (HCV).

Defuse Hepatitis C, the Viral Time Bomb: Test and Treat Hepatitis C

May 16, 2014
Chad Cipiti

Position Paper for the 67th World Health Assembly, May 19–24, 2014 The World Health Organization (WHO) has referred to hepatitis C as a “viral time bomb.” In 2010, the 63rd World Health assembly (WHA) adopted the first resolution on viral…

TAGline Spring 2014

March 31, 2014
Chad Cipiti

NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS Spring 2014 The April Fools' Issue: April 1. This is the day upon which we are reminded of what we are on the other three hundred and sixty-four. —Mark…

Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting

February 28, 2014
Chad Cipiti

Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies.

2013 TAG Update

December 13, 2013
Chad Cipiti

TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.

Training Manual for Treatment Advocates: Hepatitis C Virus and Coinfection with HIV

November 12, 2013
Chad Cipiti

November 2013 By Karyn Kaplan and Tracy Swan The purpose of this manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment…

TAGline Fall 2013

October 4, 2013
Chad Cipiti

The Domestic Issue: We're at a stalemate. This issue of TAGline underscores TAG’s commitment to ending AIDS in the United States and realizing the goals of the National HIV/AIDS Strategy.

Letter Urging UNITAID to Prioritize HIV/HCV Coinfection

September 25, 2013
Chad Cipiti

TAG and 134 other organizations sent this letter to underscore the need for a swift response from UNITAID to hepatitis C virus (HCV) coinfection; delays will cost lives and impede scale-up when more effective and tolerable therapies are available.

HIV i-Base/Treatment Action Group 2013 Pipeline Report calls on leaders to get the best HIV, hepatitis C virus (HCV), and tuberculosis drugs, diagnostics, and vaccines to the most people as quickly as possible

June 30, 2013
Chad Cipiti

HIV i-Base and Treatment Action Group (TAG) called on global and national leaders, research sponsors, and regulatory authorities to work together to make the best HIV, HCV, and TB drugs, diagnostics, and vaccines accessible as fast as possible, according to a report released today at the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.